This program is a multidisciplinary approach to the study of the immunopathogenesis of immunodeficiency disease, allergic states, graft-versus-host disease following bone marrow transplantation and collagen disease, particularly lupus erythematosus. B cell lines from immunodeficient patients will be studied for expression of Ig genes. T and B cells from patients with the Wiskott-Aldrich syndrome will be examined to understand the molecular basis of the glycophorin (gp 115) deficiency. The cellular basis of natural tolerance will be studied in congenic mice who are C5 deficient or C5 sufficient. The surface antigens of T cells of mice and man that are involved in lymphocyte toxicity will be defined by monoclonal antibodies. Control of Ia expression on murine and human macrophages will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
2P50AI021163-05
Application #
3105060
Study Section
Allergy, Immunology, and Transplantation Research Committee (AITC)
Project Start
1983-01-01
Project End
1991-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115